Mostrar el registro sencillo del ítem

dc.contributorFacultad de Veterinariaes_ES
dc.contributor.authorRoncador, Giovanna
dc.contributor.authorEngel, Pablo
dc.contributor.authorMaestre, Lorena
dc.contributor.authorAnderson, Amanda P.
dc.contributor.authorCordell, Jacqueline L.
dc.contributor.authorCragg, Mark S.
dc.contributor.authorŠerbec, Vladka Č.
dc.contributor.authorJones, Margaret
dc.contributor.authorLisnic, Vanda J.
dc.contributor.authorKremer, Leonor
dc.contributor.authorLi, Demin
dc.contributor.authorKoch-Nolte, Friedrich
dc.contributor.authorPascual, Núria
dc.contributor.authorRodríguez Barbosa, José Ignacio 
dc.contributor.authorTorensma, Ruurd
dc.contributor.authorTurley, Helen
dc.contributor.authorPulford, Karen
dc.contributor.authorBanham, Alison H.
dc.contributor.otherSanidad Animales_ES
dc.date2016
dc.date.accessioned2024-04-18T05:58:55Z
dc.date.available2024-04-18T05:58:55Z
dc.identifier.citationRoncador, G., Engel, P., Maestre, L., Anderson, A. P., Cordell, J. L., Cragg, M. S., Šerbec, V. Č., Jones, M., Lisnic, V. J., Kremer, L., Li, D., Koch-Nolte, F., Pascual, N., Rodríguez Barbosa, J.-I., Torensma, R., Turley, H., Pulford, K., & Banham, A. H. (2016). The European antibody network’s practical guide to finding and validating suitable antibodies for research. mAbs, 8(1), 27-36. https://doi.org/10.1080/19420862.2015.1100787es_ES
dc.identifier.issn1942-0862
dc.identifier.otherhttps://www.tandfonline.com/doi/full/10.1080/19420862.2015.1100787es_ES
dc.identifier.urihttps://hdl.handle.net/10612/19897
dc.description.abstract[EN]Antibodies are widely exploited as research/diagnostic tools and therapeutics. Despite providing exciting research opportunities, the multitude of available antibodies also offers a bewildering array of choice. Importantly, not all companies comply with the highest standards, and thus many reagents fail basic validation tests. The responsibility for antibodies being fit for purpose rests, surprisingly, with their user. This paper condenses the extensive experience of the European Monoclonal Antibody Network to help researchers identify antibodies specific for their target antigen. A stepwise strategy is provided for prioritising antibodies and making informed decisions regarding further essential validation requirements. Web-based antibody validation guides provide practical approaches for testing antibody activity and specificity. We aim to enable researchers with little or no prior experience of antibody characterization to understand how to determine the suitability of their antibody for its intended purpose, enabling both time and cost effective generation of high quality antibody-based data fit for publication.es_ES
dc.languageenges_ES
dc.publisherTaylor and Francis Groupes_ES
dc.rightsAtribución-NoComercial 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/*
dc.subjectInmunologíaes_ES
dc.subjectVeterinariaes_ES
dc.subject.otherBLAST searcheses_ES
dc.subject.otherCiteAbes_ES
dc.subject.otherEuroMAbNetes_ES
dc.subject.otherFlow cytometryes_ES
dc.subject.otherGene silencinges_ES
dc.subject.otherHLDA workshopses_ES
dc.subject.otherImmunohistochemistryes_ES
dc.subject.otherMonoclonal antibodieses_ES
dc.subject.otherValidation studieses_ES
dc.subject.otherWestern blottinges_ES
dc.titleThe European antibody network's practical guide to finding and validating suitable antibodies for researches_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.identifier.doi10.1080/19420862.2015.1100787
dc.description.peerreviewedSIes_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/MINECO/Programa Estatal de I+D+I Orientada a los Retos de la Sociedad/ PI14/00703/ES/ Anticuerpos Anti-CCR9 para Inmunoterapia Antitumoral en Pacientes con Leucemia Linfoblástica Aguda de Inmunofenotipo T (LLAT)es_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/Junta de Castilla y León/Otro/LE007A10-2/ES/ El papel de la ruta de co-estimulación HVEM/LIGHT como diana terapéutica para la prevención del rechazoes_ES
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses_ES
dc.identifier.essn1942-0870
dc.journal.titlemAbses_ES
dc.volume.number8es_ES
dc.issue.number1es_ES
dc.page.initial27es_ES
dc.page.final36es_ES
dc.type.hasVersioninfo:eu-repo/semantics/publishedVersiones_ES
dc.subject.unesco3109 Ciencias Veterinariases_ES
dc.subject.unesco3109.03 Inmunologíaes_ES
dc.subject.unesco2412 Inmunologíaes_ES
dc.description.projectOur research has been supported by funding from Cancer Research UK (Program A10702 to A.H.B) and Bloodwise (Program 13047 to A.H.B). The research was supported by the National Institute for Health Research (NIHR) Oxford Biomedical Research Center based at Oxford University Hospitals NHS Trust and University of Oxford. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. Grant No 310/6 from the Deutsche Forschungsgemeinschaft to F.K.-N. Grants from the Instituto de Salud Carlos III (PI14/00703, PN de I+D+I 2013-2016) and the CSIC (201320E109 and 201420E109) to L.K. laboratory. Grants of the Spanish Ministry of Health (Fondo de Investigaciones Sanitarias, PI10/01039), Department of Education of Castilla and León Regional Government (Grant# LE007A10–2) and Mutua Madrileña Foundation (Basic research grants 2012) to J.I.R.B. This work was supported by a grant from the Dutch government to the Netherlands Institute for Regenerative Medicine (NIRM, grant No. FES0908).es_ES


Ficheros en el ítem

Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución-NoComercial 4.0 Internacional
Excepto si se señala otra cosa, la licencia del ítem se describe como Atribución-NoComercial 4.0 Internacional